ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,599.30
0.00%
US Tech 100
18,994.00
-0.43%
다우존스 지수
41,350.93
0.00%
Bitcoin
82,820.36
-1.02%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Vaxcyte Inc (PCVX)

  7. Vaxcyte Inc (PCVX) 뉴스

PCVX

Vaxcyte (PCVX)

Vaxcyte Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:PCVX
일자시간출처헤드라인심볼기업
2025/03/0806:43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCVXVaxcyte Inc
2025/03/0606:10Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PCVXVaxcyte Inc
2025/03/0411:16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCVXVaxcyte Inc
2025/03/0411:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCVXVaxcyte Inc
2025/03/0411:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCVXVaxcyte Inc
2025/03/0411:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCVXVaxcyte Inc
2025/03/0406:06Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PCVXVaxcyte Inc
2025/02/2606:42Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:PCVXVaxcyte Inc
2025/02/2606:11Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:PCVXVaxcyte Inc
2025/02/2606:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PCVXVaxcyte Inc
2025/02/2606:01GlobeNewswire Inc.Vaxcyte Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business UpdateNASDAQ:PCVXVaxcyte Inc
2025/02/1306:05GlobeNewswire Inc.Vaxcyte to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025NASDAQ:PCVXVaxcyte Inc
2025/02/0806:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCVXVaxcyte Inc
2025/02/0606:01Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PCVXVaxcyte Inc
2025/02/0522:00GlobeNewswire Inc.Vaxcyte Advances to Second Stage of Ongoing Phase 2 Study Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease in InfantsNASDAQ:PCVXVaxcyte Inc
2025/02/0509:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCVXVaxcyte Inc
2025/02/0406:05Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PCVXVaxcyte Inc
2025/01/3106:05GlobeNewswire Inc.Vaxcyte to Present at the Guggenheim SMID Cap Biotech ConferenceNASDAQ:PCVXVaxcyte Inc
2025/01/1806:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCVXVaxcyte Inc
2025/01/1606:04Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PCVXVaxcyte Inc
2025/01/0806:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCVXVaxcyte Inc
2025/01/0715:13PR Newswire (US)Kuehn Law Encourages Investors of Vaxcyte, Inc. to Contact Law FirmNASDAQ:PCVXVaxcyte Inc
2025/01/0706:02Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PCVXVaxcyte Inc
2025/01/0408:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCVXVaxcyte Inc
2025/01/0306:10Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PCVXVaxcyte Inc
2024/12/1906:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCVXVaxcyte Inc
2024/12/1008:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCVXVaxcyte Inc
2024/12/0606:04Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PCVXVaxcyte Inc
2024/12/0409:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCVXVaxcyte Inc
2024/12/0322:00GlobeNewswire Inc.Vaxcyte Initiates Phase 2 Study Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease in InfantsNASDAQ:PCVXVaxcyte Inc
 검색 관련기사 보기:NASDAQ:PCVX

최근 히스토리

NYSE
MCD
McDonalds
COIN
ADAUSD
Cardano
FX
USDEUR
US Dollar vs Euro
NYSE
JPM
JP Morgan Chase
COIN
AVAXUSD
Avalanche
NASDAQ
TSLA
Tesla
NASDAQ
NVDA
NVIDIA
COIN
XRPUSD
Ripple
USOTC
RHHBY
Roche (QX)
NASDAQ
AMZN
Amazon.com
NYSE
DIS
Walt Disney
FX
USDGBP
US Dollar vs Sterling
NASDAQ
MSFT
Microsoft
COIN
SOLUSD
Solana
USOTC
ADDYY
Adidas (QX)
NASDAQ
AAPL
Apple
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지